You are viewing the site in preview mode

Skip to main content

Advertisement

Table 8 Predictors of survival in patients suffering from pyogenic liver abscess

From: The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses

  Univariate analysis Multivariate analysis
Variables OR (95% CI) P value OR (95% CI) P value
Age 0.99 (0.95–1.04) 0.73   
Male gender 0.86 (0.22–3.38) 0.83   
Predisposing disease
 Malignancy 0.22 (0.05–0.93) 0.04 0.19 (0.04–0.94) 0.041
 Liver cirrhosis 0.77 (0.14–4.18) 0.77   
 Diabetes mellitus 1.38 (0.27–7.19) 0.70   
Medication
 Proton-pump inhibitor use 0.68 (0.13–3.52) 0.64   
 Immunosuppression 0.85 (0.16–4.57) 0.85   
Blood values
 C-reactive Protein 1.10 (0.98–1.23) 0.10   
 WBC 0.98 (0.91–1.06) 0.56   
 Bilirubin 0.85 (0.75–0.98) 0.02 0.85 (0.75–0.97) 0.015
 Creatinine 0.63 (0.26–1.53) 0.30   
 INR 0.44 (0.10–1.99) 0.29   
Cholangitis 0.19 (0.04–0.98) 0.046   
MDRO 0.75 (0.17–3.26) 0.70   
Mycotic coinfection 0.41 (0.10–1.67) 0.22   
Initial empirical antibiotic treatment    
 Carbapenem based 0.60 (0.15–2.33) 0.46   
 Glycopeptide based 1.12 (0.26–4.79) 0.88   
 Tigecycline based 0.79 (0.08–7.56) 0.84   
 Metronidazole based 2.89 (0.33–25.03) 0.33